Skip to main content

Academy Urges CMS to Address Prior Authorization, Other Burdens in Medicare Advantage Plans

We raised concerns about how these delays in treatment exacerbate health care disparities.

The Academy used a recent call for input on improvements to the Medicare Advantage Program to reiterate our concerns about administrative burdens. In comments submitted to the Centers for Medicare & Medicaid Services (CMS), we urged the agency to increase oversight of plans and reinstate a ban on step therapy.

CMS recently sought public comment on ways to improve the Medicare Advantage program. The agency wanted input on several goals:

  • Improve health equity, given growing awareness of disparities among Medicare patients.
  • Expand access to care, especially for underserved communities.
  • Encourage innovation to improve the quality of care provided.

CMS also sought input on how to improve its partner relationships and ensure Medicare Advantage remains affordable and sustainable.

The Academy focused on three issues in our comments: , step therapy and onerous record requests. We noted the many issues caused by Aetna’s albeit short-lived .

We also highlighted the growing disparities caused in 2019 when CMS allowed step therapy to return to Medicare Advantage plans for Part B medications. This policy delays care for Medicare Advantage and harms seriously ill patients. Compared with fee-for-service patients, they are disproportionately lower-income, Black or Latino and more often dually enrolled in Medicaid.

We urged CMS to reinstate its previous ban on step therapy, to ensure all Medicare patients get equal and timely access to the treatments they need.

Lastly, the Academy urged CMS to address burdensome record requests to medical practices. These requests often fail to clarify or address insurers’ underlying goals, and they may also contribute to dubious billing practices by Medicare Advantage plans.

We will continue to use every opportunity to address the administrative burdens you face and the ways they delay patients’ timely access to medically necessary treatment.

 

Related Stories

Member exclusive - Locked
Step therapy has to go

Federal Watchdog to Investigate Step Therapy in Medicare Advantage Plans, at Academy’s Urging

The Academy met with the HHS Office of Inspector to continue pressing our concerns about step therapy. The meeting follows the OIG’s September 15 announcement that it will review how Medicare Advantage plans use prior authorization and step therapy for Part B drugs, a review the Academy urged.  
 

Member exclusive - Locked
Advocacy Booth 2025

Advocacy at AAO 2026

AAO 2026 is a great time to delve into the Academy's advocacy efforts and meet those who are making a difference in federal and state legislation. Whether you stop by the OPHTHPAC® and Safe Surgery Action Fund (formerly the Surgical Scope Fund) booths to learn about our work, join us at our reception, or attend one of our advocacy sessions, we’re looking forward to seeing you this year in New Orleans. All sessions are in Central Time.

Member exclusive - Locked Fallback image

CMS Tests Prior Authorization for Some ASC Services

The Centers for Medicare & Medicaid Services (CMS) has introduced a new pilot program requiring prior authorization (PA) for fee-for-service Medicare for certain services in ambulatory surgical centers (ASCs).

Latest Updates

Member exclusive - Locked
capital building side

OPHTHPAC Midterms Recap: What the Results Mean for Ophthalmology

The 2026 midterm results are nearly final, and thanks to the support of ophthalmologists nationwide, OPHTHPAC helped secure important victories for ophthalmology this election cycle: 100 of 114 OPHTHPAC-backed candidates won their general election races, with a few results still being finalized. Here is what this year’s results mean for ophthalmology.

Member exclusive - Locked
capital building side

Final Hospital Outpatient, ASC Rule: Pay Raises for Device-Intensive Procedures, But Cuts to Other Common Ophthalmic Surgeries

Hospital outpatient departments (HOPD) and ambulatory surgical centers will get a 2.3% payment increase in 2027. But the rule released Nov. 4 by the Centers for Medicare & Medicaid Services includes hidden reimbursement cuts for most ophthalmology surgeries.

Member exclusive - Locked
HHS

2027 Fee Schedule Finalizes Pay Cut to Physicians Between 1.8% and 2.3%

The final rule from the Centers for Medicare & Medicaid Services (CMS) includes a 2.31% payment cut for physicians not participating in qualifying APMs and a 1.83% pay cut for qualifying Alternative Payment Model (APM) participants.